Skip to content
AT
Company

Updated:

AMICUS THERAPEUTICS, INC.

AMICUS THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001178879, and its reported...

Overview

AMICUS THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001178879, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-02-20, it reported annual revenue of USD 634,210,000; net income of USD -27,110,000; total assets of USD 949,870,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
AMICUS THERAPEUTICS, INC.
Former names in filing history
AMICUS THERAPEUTICS INC (2002-07-25 to 2018-11-14)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Princeton, NJ, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001178879

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2025USD$634.2M-$27.1M$949.9M$214.0M$33.1M
FY2024USD$528.3M-$56.1M$785.0M$213.8M-$33.9M
FY2023USD$399.4M-$151.6M$777.9M$247.0M-$69.1M
FY2022USD$329.2M-$236.6M$724.2M$148.8M-$166.6M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-KFORM 8-K
10-K10-K
8-KFORM 8-K
8-K8-K
8-K8-K
10-Q10-Q
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research AMICUS THERAPEUTICS, INC. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

AMICUS THERAPEUTICS, INC. | Princeton Company | Altss